about
The impact of biological interventions for ulcerative colitis on health-related quality of lifeVedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices.Vedolizumab for Crohn's disease.Saudi Gastroenterology Association position statement on safety issues associated with the use of domperidoneEffect of public knowledge, attitudes, and behavior on willingness to undergo colorectal cancer screening using the health belief modelA Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel diseaseThe safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single canadian tertiary care centreAdvances in the diagnosis and management of inflammatory bowel disease: challenges and uncertainties.Vedolizumab for the treatment of moderately to severely active ulcerative colitis.C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.Risk Stratification of Patients with Crohn's Disease: A Retrospective Analysis of Clinical Decision Making and Its Impact on Long-Term Outcome.Development and validation of a histological index for UC.Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.Duct-to-Duct Biliary Anastomosis Yields Similar Outcomes to Roux-en-Y Hepaticojejunostomy in Liver Transplantation for Primary Sclerosing Cholangitis.Self-Screening for Malnutrition Risk in Outpatient Inflammatory Bowel Disease Patients Using the Malnutrition Universal Screening Tool (MUST).Reproducibility of histological assessments of disease activity in UC.Nonutility of routine testing of stool for ova and parasites in a tertiary care Canadian centre.Retrospective analysis of disease association and outcome in histologically confirmed ischemic colitis.The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centre.Does the increasing trend of colorectal cancer incidence in jeddah reflect a rise in the Kingdom of Saudi Arabia?
P50
Q24187078-B0041737-0143-464E-8500-2D871A83E651Q30300234-198D270A-14A5-4ADB-8A9D-940DC0405CAFQ31148096-7E110B4D-2BA7-48F4-BD05-D5196BCC6C47Q34326912-70B54137-3164-4F38-91BD-879F545505F6Q34335273-24625656-1A9E-41EF-A463-5AEBFA21269EQ35355624-40FA21BA-0EBB-4F6F-96AE-3DD065571053Q35973766-2D0A0E27-147A-44C5-9927-7FC8B6072E0BQ37100432-75267323-88B1-4061-9EC0-FE8A9C163CA9Q37703514-421194B9-235D-48FF-AC00-450F4792ACACQ38425873-5E547AD6-D96A-488F-8157-CFBCE64D69E2Q38474301-832362A4-A4E3-4ABF-ABA6-D0E78E0711B1Q38706667-19F34041-4145-4A3F-B1E2-6382CEC9AEACQ40421847-27CBF87F-F870-49A4-9945-390BD5450211Q40520588-08367B00-BB02-4AF5-BFE3-9193EBB649C1Q40867303-0C2DA90D-77CE-4708-A50C-9F4016BC3001Q43604157-C2C1F0EB-9DBF-4744-8AF9-C17CFC83C729Q46375131-4E6AFA5A-D9EF-43FA-A2D5-CB318B078394Q47841300-5A38AC27-0F8D-4A1A-BF22-7ED2D8BF24BAQ51272849-B13070E5-D909-4592-AE42-888C2155427AQ54454921-BCB8F592-128E-478F-A164-DD30AE963107Q86288086-3D31C479-58DB-4A79-9C10-4717778A8322
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mahmoud H. Mosli
@ast
Mahmoud H. Mosli
@en
Mahmoud H. Mosli
@es
Mahmoud H. Mosli
@nl
Mahmoud H. Mosli
@sl
type
label
Mahmoud H. Mosli
@ast
Mahmoud H. Mosli
@en
Mahmoud H. Mosli
@es
Mahmoud H. Mosli
@nl
Mahmoud H. Mosli
@sl
prefLabel
Mahmoud H. Mosli
@ast
Mahmoud H. Mosli
@en
Mahmoud H. Mosli
@es
Mahmoud H. Mosli
@nl
Mahmoud H. Mosli
@sl
P106
P1153
55203394500
P21
P31
P496
0000-0002-6975-1297